chrX-154552187-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting
The NM_001099857.5(IKBKG):c.185G>A(p.Arg62Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,185,714 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001099857.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IKBKG | NM_001099857.5 | c.185G>A | p.Arg62Gln | missense_variant, splice_region_variant | 2/10 | ENST00000594239.6 | NP_001093327.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IKBKG | ENST00000594239.6 | c.185G>A | p.Arg62Gln | missense_variant, splice_region_variant | 2/10 | 1 | NM_001099857.5 | ENSP00000471166 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000981 AC: 11AN: 112141Hom.: 0 Cov.: 23 AF XY: 0.0000875 AC XY: 3AN XY: 34283
GnomAD3 exomes AF: 0.0000241 AC: 4AN: 166227Hom.: 0 AF XY: 0.0000376 AC XY: 2AN XY: 53225
GnomAD4 exome AF: 0.000150 AC: 161AN: 1073573Hom.: 0 Cov.: 29 AF XY: 0.000125 AC XY: 43AN XY: 343741
GnomAD4 genome AF: 0.0000981 AC: 11AN: 112141Hom.: 0 Cov.: 23 AF XY: 0.0000875 AC XY: 3AN XY: 34283
ClinVar
Submissions by phenotype
Ectodermal dysplasia and immunodeficiency 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Immunology, University Hospital Southampton NHSFT | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 11, 2024 | Variant summary: IKBKG c.185G>A (p.Arg62Gln) results in a conservative amino acid change located in the NF-kappa-B essential modulator NEMO, N-terminal domain (IPR021063) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 166227 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.185G>A has been reported in the literature in a hemizygous individual affected with primary immunodeficiency (Rae_2018). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29077208). ClinVar contains an entry for this variant (Variation ID: 430903). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2021 | Unlikely to be causative of incontinentia pigmenti (XLD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | IKBKG: PS4:Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at